PI3K-AKT-mTOR inhibitors in breast cancers: From tumor cell signaling to clinical trials

詳細情報 詳細情報について

• CRID

  1360576120710722688

• DOI

  10.1016/j.pharmthera.2017.02.037

• ISSN

  01637258

• Web Site

  https://api.elsevier.com/content/article/PII:S0163725817300517?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S0163725817300517?httpAccept=text/plain

• データソース種別

  • Crossref